Cipla Limited
CIPLA · NSE · Pharmaceuticals · Generics
Tentang perusahaan
Cipla is one of India's oldest and largest pharmaceutical companies, manufacturing generic medicines, biosimilars, and active pharmaceutical ingredients for markets in India, Africa, the United States, and Europe. The company is known for its role in making antiretroviral medicines accessible at low cost in Africa. It is a Nifty 50 constituent.
| Bursa | NSE |
| Kode saham | CIPLA |
| Sektor | Pharmaceuticals · Generics |
| Kapitalisasi pasar indikatif USD | $12.00B |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (NSE), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — pencatatan resmi di bursa
Hanya informasi ketersediaan, bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di India
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset, bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.